Clinical trials in Wetteren

Investigating immune responses to respiratory syncytial virus (RSV) through vaccine trials targeting adults over 60 years. The research explores co-administration with pneumococcal vaccines to enhance protection against respiratory infections.

• RSV Prevention in Older Adults
• Vaccine Co-administration Studies
• Immune Response Assessment

These trials aim to evaluate vaccine safety and effectiveness in preventing RSV-associated diseases in the elderly population.

Clinical research focusing on hypertriglyceridemia (HTG) treatment using innovative therapeutic approaches. Studies are evaluating the long-term safety and efficacy of new medications for managing elevated triglyceride levels.

• Triglyceride Level Management
• Long-term Treatment Safety
• Metabolic Disease Therapy

The research aims to develop effective treatments for patients with varying degrees of triglyceride disorders.

Specialized trials examining treatments for severe hypertriglyceridemia (SHTG), with a focus on reducing fasting serum triglyceride levels through innovative therapeutic agents.

• Severe Lipid Disorders
• Serum Triglyceride Reduction
• Novel Treatment Approaches

These studies are designed to evaluate new therapeutic options for managing severe cases of elevated triglycerides.